oncosil medical ltd
Verified IntelOncoSil Medical is a Sydney-based medical device company focused on Interventional Oncology in the pancreas and liver. OncoSil Medical has developed a medical device called the OncoSil System, and is progressing towards its commercialisation. The device is currently undergoing clinical studies in leading academic sites globally. The clinical data will be used for regulatory submission within targeted markets including Europe, United States, Australia and Asia. OncoSil is a brachytherapy device that implants a pre-determined dose of beta radiation via injection under Endoscopic Ultrasound (EUS) guidance. The beta particles emitted by OncoSil travel a short distance in tissue causing damage to targeted cell DNA, which renders them incapable of further cell division and proliferation. OncoSil Medical is currently undertaking clinical studies to investigate the clinical benefit of the addition of OncoSil when combined with standard of care chemotherapies in the pancreas. Details on this site may include information regarding OncoSil, which may not currently have approval in your region.
OncoSil Medical is a Sydney-based medical device company focused on Interventional Oncology in the pancreas and liver. OncoSil Medical has developed a medical device called the OncoSil System, and is progressing towards its commercialisation. The device is currently undergoing clinical studies in leading academic sites globally. The clinical data will be used for regulatory submission within targeted markets including Europe, United States, Australia and Asia. OncoSil is a brachytherapy device that implants a pre-determined dose of beta radiation via injection under Endoscopic Ultrasound (EUS) guidance. The beta particles emitted by OncoSil travel a short distance in tissue causing damage to targeted cell DNA, which renders them incapable of further cell division and proliferation. OncoSil Medical is currently undertaking clinical studies to investigate the clinical benefit of the addition of OncoSil when combined with standard of care chemotherapies in the pancreas. Details on this site may include information regarding OncoSil, which may not currently have approval in your region.
Corporate Firmographics
Entity classification and operating profile
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- Undisclosed
- Employee Bracket
- 11-50
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- Suite 402, Level 4, 50 Berry Street, North Sydney NSW Sydney
- City
- Sydney
- Region / State
- New South Wales
- Postal Code
- 2060
- Country
- Australia
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for oncosil medical ltd.